Table 3.
Multivariate logistic regression analysis of factors associated with normalized alanine aminotransferase and sustained remission of ursodeoxycholic acid monotherapy in autoimmune hepatitis patients
| Factor | Category | Odds ratio (95%CI) | P |
| ALT (IU/L) | > 200 | 1 | |
| ≤ 200 | 10.8 (1.64-71.0) | 0.013 | |
| Age | > 50 | 1 | |
| ≤ 50 | 1.16 (0.21-6.38) | 0.86 | |
| IgG | > 2000 | 1 | |
| ≤ 2000 | 0.65 (0.10-4.32) | 0.66 | |
| Acute presentation | No | 1 | |
| Yes | 4.13 (0.15-110.5) | 0.4 | |
| Histological Grading | A2 or A3 | 1 | |
| A1 | 0.76 (0.10-5.88) | 0.8 | |
| Histological Staging | F2 or F3 or F4 | 1 | |
| F1 | 0.41 (0.04-4.44) | 0.46 | |
| AIH score | > 15 | 1 | |
| (International diagnostic criteria) | ≤ 15 | 2.66 (0.43-16.48) | 0.29 |
| AIH score | > 6 | 1 | |
| (Simplified criteria) | ≤ 6 | 5.46 (0.37-81.3) | 0.22 |
ALT: Alanine aminotransferase; AIH: Autoimmune hepatitis.